Ranexa (ranolazine extended-release tablets) for the treatment of chronic angina does not depend upon reductions in heart rate or blood pressure http://www.ranexa.com/wir_indications.html
  spacer  
spacer
 
right header
Clinical Studies
 

Efficacy

title right border
spacer spacer spacer
left border
Learn more about the two Ranexa pivotal studies that included approximately 1400 patients:

Ranexa has been evaluated in patients who were also taking commonly used doses of other antianginal medications.

Learn more about CARISA link right arrow
Combination Assessment of Ranexa In Stable Angina

Ranexa has also been evaluated in patients with chronic angina who remained symptomatic despite treatment with the maximum dose of an antianginal agent.

Learn more about ERICA link right arrow
Efficacy of Ranexa In Chronic Angina

spacer
spacer spacer spacer
left border
See full Prescribing Information link right arrow
Back to top
spacer
 
 
yellow footer
CVT Logo This website is intended for
US Healthcare Professionals only